European Journal of Radiology
Volume 62, Issue 2 , Pages 175-179 , May 2007

Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: A prospective randomised study

  • Vlastimil Válek

      Affiliations

    • Department of Radiology, FN Brno and LF MU Brno, Jihlavská 20, CZ-36900 Brno, Czech Republic
    • Corresponding Author InformationCorresponding author. Tel.: +420 547193007; fax: +420 547192383.
    • ,
  • Petr Kysela

      Affiliations

    • Department of Surgery, FN Brno and LF MU Brno, Jihlavská 20, CZ-36900 Brno, Czech Republic
    • ,
  • Zdenek Kala

      Affiliations

    • Department of Surgery, FN Brno and LF MU Brno, Jihlavská 20, CZ-36900 Brno, Czech Republic
    • ,
  • Igor Kiss

      Affiliations

    • Department of Oncology, FN Brno and LF MU Brno, Jihlavská 20, CZ-36900 Brno, Czech Republic
    • ,
  • Jiří Tomášek

      Affiliations

    • Department of Oncology, FN Brno and LF MU Brno, Jihlavská 20, CZ-36900 Brno, Czech Republic
    • ,
  • Jiří Petera

      Affiliations

    • Department of Oncology and Radiotherapy, Charles University Medical School and Teaching Hospital, 50005, Czech Republic

Received 26 January 2007 ,Accepted 31 January 2007.

References 

  1. Chahal P, Baron TH. Cholangiocarcinoma. Curr Treat Options Gastroenterol. 2005;8(December):493–502
  2. Eschelman DJ, Shapiro MJ, Bonn J, et al. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy. Radiology. 1996;200:717–724
  3. Deodato F, Clemente G, Mattiucci GC, et al. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results. Int J Radiat Oncol Biol Phys. 2006;64(2):483–488
  4. Leung J, Guiney M, Das R. Intraluminal brachytherapy in bile duct carcinomas. Aust NZ J Surg. 1996;66:74–77
  5. Zhang FJ, Wu PH, Gu YK, Zhao M, Fan WJ, Xiao XS. Clinical value of brachytherapy of malignant biliary obstruction after implanting expandable metallic biliary endoprothesis. Ai Zheng. 2004;23(11):1567–1571
  6. Kocak Z, Ozkan H, Adli M, et al. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct. Radiat Med. 2005;23(3):200–207
  7. Takamura A, Saito H, Kamada T, et al. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. It J Radiat Oncol Biol Phys. 2003;57(5):1357–1365
  8. Bowling TE, Galbraith SM, Hatfield AR, Solano J, Spittle MF. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut. 1996;39(96):852–855
  9. Golfieri R, Giampalma E, Fusco F, et al. Unresectable hilar cholangiocarcinoma: multimodality treatment with percutaneous and intraluminal plus external radiotherapy. J Chemother. 2004;5(16):55–57
  10. Montemaggi P, Costamagna G, Dobelbower RR, et al. Intraluminal brachytherapy in the treatement of pancreas and bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1995;32:437–443
  11. Montemaggi P, Morganti AG, Dobelbower RR, et al. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?. Radiology. 1996;199:861–866
  12. Czito BG, Anscher MS, Willett CG. Radiation therapy in the treatment of cholangiocarcinoma. Oncology. 2006;20(8):873–884

PII: S0720-048X(07)00059-9

doi: 10.1016/j.ejrad.2007.01.037

European Journal of Radiology
Volume 62, Issue 2 , Pages 175-179 , May 2007

Article Tools

* Image Usage & Resolution